SavedAdd your journal

Journals / Namık Kemal Tıp Dergisi / 2018 / Cilt: 6 - Sayı: 2

CAN VITAMIN D DEFICIENCY PREDICT CORONARY ARTERY DISEASE?

Vitamin D Eksikliği Koroner Arter Hastalığı İçin Öngördürücü müdür?

Demet ÖZKARAMANLI GÜR
Aydın AKYÜZ
Birol TOPÇU
Seref ALPSOY
Hasan DEĞİRMENCİ
Pages
45–52
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A positive correlation wasfound between the vitamin D and HDL-C levels (r=0.328;p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: On the basis of emerging data about the associationof vitamin D and coronary artery disease (CAD), weinvestigated whether a relationship exists among vitaminD, inflammation represented by C-reactive protein (CRP),and serum lipid profile in CAD.Materials and Methods: Patients with newly diagnosedCAD (n = 115) and 62 healthy subjects were enrolled inthe study.
📊
Key Findings & Data:Blood lipids, CRP, and vitamin D levels weremeasured, and the patient and control groups’ values werecompared.Results: The low-density lipoprotein cholesterol (LDL-C),triglyceride, and CRP levels were higher, and vitamin Dand high-density lipoprotein cholesterol (HDL-C) levelswere lower in the patient group.
💡
Conclusion & Impact:A positive correlation wasfound between the vitamin D and HDL-C levels (r=0.328;p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: On the basis of emerging data about the associationof vitamin D and coronary artery disease (CAD), weinvestigated whether a relationship exists among vitaminD, inflammation represented by C-reactive protein (CRP),and serum lipid profile in CAD.Materials and Methods: Patients with newly diagnosedCAD (n = 115) and 62 healthy subjects were enrolled inthe study. Blood lipids, CRP, and vitamin D levels weremeasured, and the patient and control groups’ values werecompared.Results: The low-density lipoprotein cholesterol (LDL-C),triglyceride, and CRP levels were higher, and vitamin Dand high-density lipoprotein cholesterol (HDL-C) levelswere lower in the patient group. A positive correlation wasfound between the vitamin D and HDL-C levels (r=0.328;p

Özet

Amaç: D vitamininin ve koroner arter hastalığının (KAH) ilişkisiyle ilgili ortaya çıkan verilere dayanarak, KAH'da D vitamini ile C-reaktif protein (CRP) ile temsil edilen inflamasyon ve serum lipid profili arasında ilişki bulunup bulunmadığını araştırdık. Materyal ve Metot: Yeni KAH tanısı konmuş 115 hasta ve 62 sağlıklı birey çalışmaya alındı. Kan lipidleri, CRP ve D vitamini düzeyleri ölçüldü ve hasta ve kontrol gruplarının değerleri karşılaştırıldı. Bulgular: Hasta grubunda düşük dansiteli lipoprotein kolesterol (DDL-K), CRP ve trigliserit düzeyleri yüksek, vitamin D ve yüksek dansiteli lipoprotein kolesterol (YDLK) düşüktü. Vitamin D ile YDL-K arasında pozitif korelasyon (r=0.328; p

🔖

Cite This Article

GÜR, D. Ö., AKYÜZ, A., TOPÇU, B., ALPSOY, S., DEĞİRMENCİ, H. (2022). CAN VITAMIN D DEFICIENCY PREDICT CORONARY ARTERY DISEASE?. Namık Kemal Tıp Dergisi, Cilt: 6 - Sayı: 2, 45–52. https://ajindex.com/articles/584108

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012; 366:54-63.
  2. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment, Review. Circulation. 2004;109 (23): III15-9. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340(5):115–26.
  3. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6(7):508-19.
  4. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al. For the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. ArteriosclerThromb Vasc Biol. 2002;22(5):838-42.
  5. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256(20):2835-8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97.
  6. Kontush A, Chapman MJ. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med. 2006;3(3):144-53. Duffy D. Rader DJ. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol. 2009;6(7):455-63.
  7. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009;338(1):40-4. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353-73.
  8. Nadir MA, Szwejkowski BR, Witham MD. Vitamin D and cardiovascular prevention. Cardiovasc Ther. 2010;28: e5-12. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé et al. Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963-8.
  9. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am JCardiol. 2012;109(3):359-63.
  10. Seker T, Gür M, Yüksel Kalkan G